[email protected]
We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. | × |
---|
Understand the COVID-19 Outbreak and its impact on global & regional businesses
request free proposal
Insights on a world turned upside down : Re-imagining
The post-COVID19 Business resilience & recovery
How effective strategies and business recovery plans are winning the race
request free proposal
Goldstein Market Intelligence help you navigate through the COVID-19 crisis,
we will provide you most relevant market insights on crisis management,
recovery strategy & business continuity.
2019-06-18
245
Global
Market Overview
Glaucoma is the second cause of blindness after cataract, with 3 million Americans suffering from it. The global glaucoma market estimated to be USD 5 billion in 2016. Vision impairment or blindness hit the individuals when fluids are building up in the eye resulting in pressurizing the optic nerve and relieving this strain has been a challenge for ophthalmologists. In 2016, after the approval of XEN45 gel stent which is collagen-derived gelatin tube, Dr. Cristobal Cruz-Colon was the first ophthalmologist to successfully implant the XEN GEL stent at Coral Gables Surgery Center.
Allergan receives FDA clearance for the XEN Gel Stent, a new surgical treatment for refractory glaucoma and will provide the new treatment option to bring down the intraocular pressure of the struggling patients. Over 10,500 stents were distributed worldwide in 2016.
Although in Philippines is developing more substantive requirements for medical devices but specific devices like abutment, stents, injection port, abdominal pad, anesthesia set, alcohol swab, surgical blade, etc are subjected to mandatory registration.
Market Segmentation
Market Size Outlook (2016-2024)
The Gel Stent Market projected to garner USD 17.25 billion by 2024. The global gel stent market tends to reach USD 0.37 billion by 2024 at a CAGR of 30% over the forecast period. Major portion of global gel stent market contributes to research (40%) in clinical trials segment and eye research institutes (55%) in end user segment.
In terms of value, North America and Europe is expected to dominate the global gel stents market by acquiring more than 50% market share, owing to the increasing glaucoma cases with increasing geriatric population. APAC gel stents market is expected to project the highest growth rate due to rising interest in advanced and novel technology.
Growth Drivers & Challenges
The Allergan gel stent is soft which involve minimal invasive procedure, 6mm long with width of human hair approximately and permanent implant setup are the driving factors for global gel stent market. Gel stents are the breakthrough for the patients with primary open glaucoma and failed surgical treatment i.e. unresponsive to traditional medical therapy.
Main restraint in global gel stent market is that only few qualified ophthalmologist can determine if implant is suitable for patient’s condition. Product portfolio for gel stents is not big enough like other stents, mandatory registrations for medical devices and non commercialized insurance coverage for this product hinders the global gel stent market.
Key Market Players
Scope Background
Market Synopsis
Market Segmentation
The Global Gel Stent Market is segmented as follows:
By Regions
Market Dynamics: Growth Drivers, Restraints and Opportunities
Key Market Players
Porter’s Five Force Model
Market Landscape: Competition and Beyond
Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
Expert Analysis
Concluding Remarks
Gel Stents Market- Table of Content
1. Research Methodology |
1.1. Secondary Research |
1.2. Primary Research |
1.3. Data Analyzing & Market Size Estimation |
1.4. Research Design |
1.5. Bottom-Up & Top-Down Approach |
2. Market Environment |
2.1. Global Economic Overview |
2.2. Global Macroeconomic Outlook |
2.3. Global Medical Devices Market Outlook |
2.4. Global Surgical Implants Market Outlook |
2.5. Global Ophthalmology Industry Outlook |
2.6. Global Glaucoma Cases Analysis |
2.7. Regulatory Considerations |
3. Industry Structure |
3.1. Target Consumer Group Analysis |
3.2. Consumer Trend Analysis |
3.3. Target Markets (By Countries) |
3.4. Clinical Research & Development |
3.5. Demand & Supply Analysis |
3.6. Marketing & Distribution Analysis |
3.7. Trade (Import & Export) Analysis |
3.8. Investments Outlook |
4. Executive Summary |
4.1. Market Size (USD Million) |
4.2. Forecast Analysis (2017-2025) |
4.3. Market Share & CAGR (%) |
4.4. Regional Share Distribution (%) |
5. Market Dynamics |
5.1. Growth Drivers |
5.2. Market Restraints |
5.3. Risk Analysis (Demand Risk & Supply Risk Analysis) |
5.4. Recent Trends & Developments |
5.5. Opportunities for Market Players |
6. Global Gel Stent Market Segmentation |
6.1. Gel StentMarket By Clinical Trials(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.1.1. Preclinical (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.1.2. Clinical phase I/II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.1.3. Clinical phase II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.1.4. Clinical phase III (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.1.5. Research (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.1.6. Market Attractiveness Gel Stent Market by Clinical Trials |
6.1.7. BPS Analysis Gel Stent Market by Clinical Trials |
6.2. Gel StentMarket By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.2.1. Eye Clinics(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.2.2. Eye Research Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.2.3. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.2.4. Market Attractiveness of Gel Stent Market by End User |
6.2.5. BPS Analysis of Gel Stent Market by End User |
6.3. Gel StentMarket By Region (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024) |
6.3.1. North America Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.1. North America Gel StentMarket By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024) |
6.3.1.1.1. U.S. Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.1.2. Canada Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.1.3. Market Attractiveness of Gel Stent Market by Country |
6.3.1.1.4. BPS Analysis of Gel Stent Market by Country |
6.3.1.2. North America Gel Stent Market By Clinical Trials (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.2.1. Preclinical (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.2.2. Clinical phase I/II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.2.3. Clinical phase II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.2.4. Clinical phase III (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.2.5. Research (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.2.6. Market Attractiveness Gel Stent Market by Clinical Trials |
6.3.1.2.7. BPS Analysis Gel Stent Market by Clinical Trials |
6.3.1.3. North America Gel Stent Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.3.1. Eye Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.3.2. Eye Research Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.3.3. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.1.3.4. Market Attractiveness of Gel Stent Market by End User |
6.3.1.3.5. BPS Analysis of Gel Stent Market by End User |
6.3.2. Europe Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1. Europe Gel Stent Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024) |
6.3.2.1.1. UK Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.2. France Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.3. Italy Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.4. Germany Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.5. Spain Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.6. Hungary Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.7. Sweden Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.8. Russia Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.9. Poland Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.10. Rest of EuropeGel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.1.11. Market Attractiveness of Gel Stent Market by Country |
6.3.2.1.12. BPS Analysis of Gel Stent Market by Country |
6.3.2.2. Europe Gel Stent Market By Clinical Trials (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.2.1. Preclinical (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.2.2. Clinical phase I/II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.2.3. Clinical phase II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.2.4. Clinical phase III (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.2.5. Research (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.2.6. Market Attractiveness Gel Stent Market by Clinical Trials |
6.3.2.2.7. BPS Analysis Gel Stent Market by Clinical Trials |
6.3.2.3. Europe Gel Stent Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.3.1. Eye Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.3.2. Eye Research Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.3.3. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.2.3.4. Market Attractiveness of Gel Stent Market by End User |
6.3.2.3.5. BPS Analysis of Gel Stent Market by End User |
6.3.3. Middle East & Africa Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.1. Middle East & Africa Gel StentMarket By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024) |
6.3.3.1.1. Gulf Cooperation Council Countries (GCC) Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.1.2. South Africa Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.1.3. North Africa Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.1.4. Rest of Middle East and Africa Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.1.5. Market Attractiveness of Gel Stent Market by Country |
6.3.3.1.6. BPS Analysis of Gel Stent Market by Country |
6.3.3.2. Middle East & Africa Gel Stent Market By Clinical Trials (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.2.1. Preclinical (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.2.2. Clinical phase I/II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.2.3. Clinical phase II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.2.4. Clinical phase III (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.2.5. Research (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.2.6. Market Attractiveness Gel Stent Market by Clinical Trials |
6.3.3.2.7. BPS Analysis Gel Stent Market by Clinical Trials |
6.3.3.3. Middle East & Africa Gel Stent Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.3.1. Eye Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.3.2. Eye Research Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.3.3. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.3.3.4. Market Attractiveness of Gel Stent Market by End User |
6.3.3.3.5. BPS Analysis of Gel Stent Market by End User |
6.3.4. Latin America Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.1. Latin America Gel StentBy Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024) |
6.3.4.1.1. Brazil Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.1.2. Mexico Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.1.3. Rest of Latin America Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.1.4. Market Attractiveness of Gel Stent Market by Country |
6.3.4.1.5. BPS Analysis of Gel Stent Market by Country |
6.3.4.2. Latin America Gel Stent Market By Clinical Trials (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.2.1. Preclinical (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.2.2. Clinical phase I/II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.2.3. Clinical phase II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.2.4. Clinical phase III (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.2.5. Research (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.2.6. Market Attractiveness Gel Stent Market by Clinical Trials |
6.3.4.2.7. BPS Analysis Gel Stent Market by Clinical Trials |
6.3.4.3. Latin America Gel Stent Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.3.1. Eye Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.3.2. Eye Research Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.3.3. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.4.3.4. Market Attractiveness of Gel Stent Market by End User |
6.3.4.3.5. BPS Analysis of Gel Stent Market by End User |
6.3.5. Asia Pacific (APAC) Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.1. Asia Pacific Gel Stent Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024) |
6.3.5.1.1. China Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.1.2. Japan Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.1.3. India Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.1.4. Singapore Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.1.5. South Korea Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis,2016-2024) |
6.3.5.1.6. Australia Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.1.7. New Zealand Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.1.8. Rest of APAC Gel Stent Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.1.9. Market Attractiveness of Gel Stent Market by Country |
6.3.5.1.10. BPS Analysis of Gel Stent Market by Country |
6.3.5.2. Asia Pacific Gel Stent Market By Clinical Trials (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.2.1. Preclinical (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.2.2. Clinical phase I/II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.2.3. Clinical phase II (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.2.4. Clinical phase III (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.2.5. Research (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.2.6. Market Attractiveness Gel Stent Market by Clinical Trials |
6.3.5.2.7. BPS Analysis Gel Stent Market by Clinical Trials |
6.3.5.3. Asia Pacific Gel Stent Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.3.1. Eye Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.3.2. Eye Research Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.3.3. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) |
6.3.5.3.4. Market Attractiveness of Gel Stent Market by End User |
6.3.5.3.5. BPS Analysis of Gel Stent Market by End User |
7. Competitive Outlook |
7.1. Market Share of Major Players (2016) |
7.2. Competitive Strategies |
7.3. Acquisitions & Divestitures |
7.4. Company Profiles |
7.4.1. Allergan |
7.4.1.1. Company Synopsis |
7.4.1.2. Business Strategy |
7.4.1.3. Product Portfolio |
7.4.1.4. SWOT Analysis |
7.4.2. AqueSys Inc. |
7.4.3. Glaukos |
7.4.4. Innfocus |
8. Porter’s Five Force Model |
9. Market Landscape: Competition and Beyond |
10. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem |
11. Expert Analysis |
12. Concluding Remarks |
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
OR Call Us:+1-646-568-7747Global Cardiac Implants Market Analysis By Type, By Condition & by Region with Forecast 2017-2030
Global Medical Polymer Market Report by Product, by Distribution Channel, by Gender, & by Region with Forecast 2017-2030
Cardiac Pacemaker Market Report: By Product Type(Implantable, External), By Technology Type(Single & Dual Chambered, Biventricular), By Region, Industry Share, Trends, Demand, Key Players, Opportunities Assessment
Global Implantable Cardiac/Heart Pacemaker Market Report By Product Type(Single & Dual Chamber Pacemaker, Biventricular Pacemaker), By Applications(Arrhythmia, Long QT Syndrome, Tachycardia, Bradycardia, Atrial fibrillation, Heart Block), Forecast Period 2017-2025